# Doriano Fabbro

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/doriano-fabbro/

## Facts

| Field | Value |
| --- | --- |
| Citations | 29,920 |
| Field | PI3K/AKT/mTOR signaling in cancer |
| h-index | 89 |
| i10-index | 197 |
| Last Known Institution | DecImmune Therapeutics (United States) |
| OpenAlex ID | https://openalex.org/A5011479527 |
| ORCID iD | https://orcid.org/0000-0002-9400-4517 |
| Works | 349 |

## Researcher papers

- [Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia](https://scholariq.org/papers/requirement-of-src-kinases-lyn-hck-and-fgr-for-bcr-abl1-induced-b-lymphoblastic/)

## Researcher topics

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Protein Kinase Regulation and GTPase Signaling](https://scholariq.org/topics/protein-kinase-regulation-and-gtpase-signaling/)
- [Eosinophilic Disorders and Syndromes](https://scholariq.org/topics/eosinophilic-disorders-and-syndromes/)

## Researcher university

- [DecImmune Therapeutics (United States)](https://scholariq.org/institutions/decimmune-therapeutics-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.